1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262–267.
2. Joint FAO/WHO Expert Committee on Food Additives. Evaluation of certain veterinary drug residues in food: sixty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organ Tech Rep Ser. 2006; (939):1–80.
3. Harvey RS, Reffitt DM, Doig LA, et al. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther. 1998; 12:845–848.
4. Thompson KH, Liboiron BD, Sun Y, et al. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands: in vivo comparisons of anti-diabetic therapeutic potential. J Biol Inorg Chem. 2003; 8:66–74.
5. Hong YL, Pan HZ, Scott MD, Meshnick SR. Activated oxygen generation by a primaquine metabolite: inhibition by antioxidants derived from Chinese herbal remedies. Free Radic Biol Med. 1992; 12:213–218.
6. Kim YB, Oh SH, Sok DE, Kim MR. Neuroprotective effect of maltol against oxidative stress in brain of mice challenged with kainic acid. Nutr Neurosci. 2004; 7:33–39.
7. Yang Y, Wang J, Xu C, et al. Maltol inhibits apoptosis of human neuroblastoma cells induced by hydrogen peroxide. J Biochem Mol Biol. 2006; 39:145–149.
8. Seigel GM. Establishment of an E1A-immortalized retinal cell culture. In Vitro Cell Dev Biol Anim. 1996; 32:66–68.
9. Seigel GM, Sun W, Wang J, et al. Neuronal gene expression and function in the growth-stimulated R28 retinal precursor cell line. Curr Eye Res. 2004; 28:257–269.
10. Sun W, Seigel GM, Salvi RJ. Retinal precursor cells express functional ionotropic glutamate and GABA receptors. Neuroreport. 2002; 13:2421–2424.
11. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998; 16:225–260.
12. Van Antwerp DJ, Verma IM. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol Cell Biol. 1996; 16:6037–6045.
13. Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol. 2006; 6:111–130.
14. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006; 25:6680–6684.
15. Wu T, Chiang SK, Chau FY, Tso MO. Light-induced photoreceptor degeneration may involve the NF kappa B/caspase-1 pathway in vivo. Brain Res. 2003; 967:19–26.
16. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science. 1996; 274:1383–1385.
17. Nakai M, Qin ZH, Chen JF, et al. Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem. 2000; 74:647–658.
18. Fan W, Cooper NG. Glutamate-induced NFkappaB activation in the retina. Invest Ophthalmol Vis Sci. 2009; 50:917–925.
19. Chen YG, Zhang C, Chiang SK, et al. Increased nuclear factor-kappa B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice. J Neurosci Res. 2003; 72:125–131.
20. Gupta VK, You Y, Li JC, et al. Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J Mol Neurosci. 2013; 49:96–104.
21. Zhou Y, Pernet V, Hauswirth WW, Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther. 2005; 12:402–412.
22. Pernet V, Hauswirth WW, Di Polo A. Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem. 2005; 93:72–83.
23. Luo JM, Cen LP, Zhang XM, et al. PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. Eur J Neurosci. 2007; 26:828–842.
24. Cagnol S, Van Obberghen-Schilling E, Chambard JC. Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death. Apoptosis. 2006; 11:337–346.
25. Stanciu M, Wang Y, Kentor R, et al. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem. 2000; 275:12200–12206.
26. Basu K, Mukhopadhyay A, Ghosh I, Datta K. Nuclear morphology and c-Jun N-terminal kinase 1 expression differentiate serum-starved oxidative stress signalling from hydrogen peroxide-induced apoptosis in retinal neuronal cell line. Cell Biol Int. 2012; 36:1021–1027.
27. Ogura M, Kitamura M. Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. J Immunol. 1998; 161:3569–3574.
28. Seigel GM. R28 retinal precursor cells: the first 20 years. Mol Vis. 2014; 20:301–306.
29. Krishnamoorthy RR, Agarwal P, Prasanna G, et al. Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res. 2001; 86:1–12.
30. Sippl C, Tamm ER. What is the nature of the RGC-5 cell line? Adv Exp Med Biol. 2014; 801:145–154.
31. Krishnamoorthy RR, Clark AF, Daudt D, et al. A forensic path to RGC-5 cell line identification: lessons learned. Invest Ophthalmol Vis Sci. 2013; 54:5712–5719.
32. Hironishi M, Kordek R, Yanagihara R, Garruto RM. Maltol (3-hydroxy-2-methyl-4-pyrone) toxicity in neuroblastoma cell lines and primary murine fetal hippocampal neuronal cultures. Neurodegeneration. 1996; 5:325–329.
33. Gralla EJ, Stebbins RB, Coleman GL, Delahunt CS. Toxicity studies with ethyl maltol. Toxicol Appl Pharmacol. 1969; 15:604–613.
34. Anwar-Mohamed A, El-Kadi AO. Induction of cytochrome P450 1a1 by the food flavoring agent, maltol. Toxicol In Vitro. 2007; 21:685–690.